Clinical Trials Using Octreotide Acetate
Clinical trials are research studies that involve people. The clinical trials on this list are studying Octreotide Acetate. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Octreotide Acetate before or after Lanreotide Acetate in Comparing Injection Site Pain in Patients with Locally Advanced or Metastatic Well Differentiated Neuroendocrine Tumors
This randomized pilot phase IV trial studies octreotide acetate before or after lanreotide acetate in comparing injection site pain in patients with well differentiated neuroendocrine tumors that have spread from where they started to nearby tissue, lymph nodes, or other places in the body. Antihormone therapy, such as octreotide acetate and lanreotide acetate, may fight neuroendocrine tumors by blocking the use of hormones by the tumor cells.
Location: 7 locations
Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.
Study to allow access to everolimus for patients who are on everolimus treatment in a Novartis-sponsored study and are benefiting from the treatment as judged by the investigator
Location: See Clinical Trials.gov
Octreotide Acetate in Enhancing Liver Recovery in Patients with Liver Tumor after Surgery
This randomized phase II trial studies how well octreotide acetate works in enhancing liver recovery in patients with liver tumor after surgery. Octreotide acetate may enhance liver recovery in patients who undergo major hepatectomy.
Location: Fox Chase Cancer Center, Philadelphia, Pennsylvania